Skip to the page

Data / Form D filings / Torch Therapeutics, Inc.

Torch Therapeutics, Inc.: Form D filing

Torch Therapeutics, Inc., a biotechnology company in Belmont, CA, filed a Form D with the SEC in 2024. The latest, on October 8, 2024, reports $4 million sold of a $15.3 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2729 WALTHAM CROSS STREET, Belmont, CA, 94002
Phone
(650) 380-6682
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2040433

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 8, 2024New notice$15,275,000$4,025,000$11,250,0005Sep 25, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Donald G. PayanDirector, Executive Officer
Ramesh BhattDirector, Executive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Oct 7, 2024 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Torch Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.